Exagen closes $20.2M public offering at $5.25/share; net proceeds ~$18.6M

EXAGEN INC.

Offering of 3,350,000 shares plus full exercise of underwriter's option for 502,500 shares.
Gross proceeds of ~$20.2M; net proceeds after fees and expenses ~$18.6M.
Canaccord Genuity acted as sole bookrunner; offering priced at $5.25 per share.
Shares sold under effective shelf registration; proceeds for general corporate purposes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.